Advice
in the absence of a submission from the holder of the marketing authorisation:
colesevelam (Cholestagel®) is not recommended for use within NHS Scotland.
Indication under review: in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- colesevelam (Cholestagel)
- SMC ID:
- 690/11
- Indication:
- in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia.
- Pharmaceutical company
- Genzyme Therapeutics Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 07 February 2011